← All indications
Infertility
A reduced or absent capacity to reproduce.
Subtype terms (2)
More specific conditions that are subtypes of Infertility in the MeSH hierarchy.
- Infertility, Female
120 drugs (77 approved, 43 experimental)
- Infertility, Male
88 drugs (49 approved, 39 experimental)
Drugs by status
Approved for this indication (13)
Phase 4 trials (60)
- metformin
- melatonin
- 131i-lipiodol
- propofol
- vitamin d3
- norgestrel
- follitropin alfa
- urea
- a23187
- danazol
- dehydroepiandrosterone
- prednisone
- progesterone
- dydrogesterone
- ferric carboxymaltose
- somatropin
- ethinyl estradiol
- liraglutide
- leuprolide
- goserelin
- Filgrastim
- soybean oil
- meperidine
- platelet-rich plasma
- desogestrel
- myoinositol
- nafarelin
- cetrorelix
- Atosiban
- progestin
- +30 more
Phase 3 trials (25)
Phase 2 trials (26)
- ringer's lactate
- metronidazole
- denosumab
- acetylcarnitine
- allogeneic natural killer cells
- as900672
- barusiban
- emfilermin
- folic acid
- ginger
- calcium
- albumin (Human)
- icosapent ethyl
- nimodipine
- plasma rich in growth factors
- lidocaine
- allogeneic hematopoietic stem cells
- growth hormone
- alprostadil
- walnut
- thyroxine
- lactobacillus salivarius
- selisistat
- sh-ds01
- bushen culuan
- oxo-001
Phase 1 trials (10)
Other trials (28)
- plerixafor
- oxytocin
- autologous blood
- carbon dioxide
- doxycycline
- tacrolimus
- ginseng
- naltrexone
- tenofovir
- insulin human
- lorazepam
- drospirenone
- liquid nitrogen
- scopolamine
- hyaluronic acid
- mycophenolate
- glucose
- autologous endothelial progenitor cells
- oxygen
- ofloxacin
- estrone
- mefenamic acid
- glucose monohydrate
- latrunculin b
- zinc sulfate
- Lactobacillus acidophilus
- cytochalasin b
- zinc
Organizations
Organization Involved with Phase 4 Indications (169)
- Aristotle University of Thessaloniki
- Vita-Salute University of Milano. Italy
- EIPICO PHARMA, EGYPT
- ARTPred
- Kwong Wah Hospital
- University of Valencia
- Androcenter, Napoli
- Guangxi Maternal and Child Health Hospital
- Foundation for Human Reproduction
- Southern Medical University
- Fundació Privada Eugin
- University of Turku
- Ghent University
- Karolinska Institute
- Centre Hospitalier Chretien
- U.O. Chirurgia Andrologica
- Center for Human Reproduction
- Selcuk University
- Azienda Ospedaliera Antonio Cardarelli
- Michigan State University
- Colorado Center for Reproductive Medicine
- University of Ljubljana
- Hebei University
- Hacettepe University
- University Alicante
- Bayer
- AZ Jan Palfijn Gent
- Harvard University
- Universidad Autonoma de Barcelona
- Andros Day Surgery Clinic
- +139 more
Organization Involved with Phase 3 Indications (114)
- Biosearch S.A.
- Gema Biotech S.A.
- Peter MacCallum Cancer Centre
- Wayne State University
- The University of Texas, Dallas
- Imperial College London
- Government of Denmark
- Foundation for Reproductive Medicine
- University of Turin
- National Institutes of Health (NIH)
- Moorgreen Hospital, Southampton
- Herlev Hospital
- IQVIA
- BridgePharm LLC
- University of Vermont
- Dongguk University
- University of North Carolina at Chapel Hill
- University of Oulu
- University of Alberta
- Gachon University
- IVFarma LLC
- University of Colorado
- Syntax for Science
- Temple University
- Yeshiva University
- Fertility Biotech AG
- Universitarios de Xochicalco
- Yazd Research & Clinical Center for Infertility
- University of Michigan
- University of Granada
- +84 more
Organization Involved with Phase 2 Indications (37)
- Glycotope GmbH
- Dallah Healthcare Company
- Wake Forest University
- University of London
- Vinnova
- Central South University
- University of Cambridge
- Universidad Complutense de Madrid
- Beijing First Hospital of integrated Chinese and Western Medicine
- Shengjing Hospital
- Stem Cells Arabia
- University of Nigeria
- Medical University of Lublin
- Beijing Fengtai Hospital of Integrated Traditional and Western Medicine
- Capital Medical University
- Aga Khan University
- Chongqing Medical University
- Centro de Diagnóstico Médico. Ayuntamiento de Madrid.
- Duke University
- Loughborough University
- Washington University in St. Louis
- Stanford University
- Isifer AB
- University of Washington
- King Fahad Medical City
- Chinese Academy of Medical Sciences
- Mayo Clinic
- Omar Ahmed El Sayed Saad
- University of Ottawa
- Ahmed Elgazzar Hospital
- +7 more
Organization Involved with Phase 1 Indications (26)
- Zagazig University
- Virginia Center for Reproductive Medicine
- Korea University
- Grunenthal
- University of Miami
- University of Chile
- Centro de Infertilidad y Reproducción Humana
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- Alphamab Co., Ltd.
- Productos Científicos S. A. de C. V.
- University of California, Los Angeles
- El Galaa Teaching Hospital
- Berg, LLC
- Hebrew University
- University of Montreal
- Osakidetza
- AbbVie
- AstraZeneca
- University of Indonesia
- Catholic University of Sacred Heart, Rome
- The International Peace Maternity & Child Health Hospital of China welfare institute
- Beni Suef University
- Warner Chilcott
- Competence Centre on Health Technologies
- POM Wonderful LLC
- Ascendance Biomedical
Organization Involved with Other Experimental Indications (89)
- University of Missouri
- University of California, San Diego
- Servy Massey Fertility Insititute
- Medical University of Vienna
- Guangzhou Science and Technology Program key projects
- Fundación Santiago Dexeus Font
- Ginegorama S.L.
- German Hospital, Istanbul
- University of Patras
- Main Line Fertility Center
- Ostergotland County Council, Sweden
- Bezmialem University
- Disha Fertility and Surgical Centre, Indore, India
- Basque Country University
- Ibn Sina Hospital
- Goodlife Fertility B.V.
- Ege University
- NATURAmedicatrix Sarl
- Womb Transplant UK
- Bahceci Women Health Care Center
- Andrology and Fertility Hospital of Hanoi
- University of Illinois at Chicago
- University of Baghdad
- Saglik Bilimleri Universitesi
- Zhongshan Medical University
- Programa de Asistencia Reproductiva de Rosario
- Rajavithi Hospital, Bangkok
- Disha Fertility & Surgical Hospital, Indore, India
- Postgraduate Institute of Medical Education and Research
- Government of Iraq
- +59 more